NCT01725035 Hepatic De Novo Lipogenesis (DNL)in the Pathogenesis of Hepatic Steatosis in Obese Youth Status COMPLETED Phase N/A
NCT01720719 Atorvastatin Versus Vitamin E in Treatment of Non-alcoholic Fatty Liver Disease Status UNKNOWN Phase PHASE4
NCT01682655 Genetic Variant in Apolipoprotein C3 Gene and Fatty Liver in Obese Children Status COMPLETED Phase N/A
NCT01457625 Clinical Study of Serum Fetuin A Level, Insulin Resistance and Hepatic Fat Content in Dialysis Patients Status UNKNOWN Phase N/A
NCT01423630 Supplementation of Probiotics and Fruit Fibre to Patients With Fatty Liver Status TERMINATED Phase NA
NCT01284634 Study to Evaluate the Effect of GWP42003 on Liver Fat Levels in Participants With Fatty Liver Disease Status COMPLETED Phase PHASE2
NCT01282892 Visceral Abdominal Fat, Non Alcoholic Fatty Liver Diseases and Asymptomatic Coronary Atherosclerosis Status UNKNOWN Phase N/A
NCT01234714 Liver Fat Quantification by Magnetic Resonance Imaging (MRI) - Prediction of Postoperative Complications Status COMPLETED Phase N/A
NCT01147523 Effect of Spironolactone and Vitamin E in Patients With Nonalcoholic Fatty Liver Disease Status COMPLETED Phase PHASE2
NCT01100398 Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) Utilizing Ultrasound and Percutaneous Liver Biopsy Status COMPLETED Phase N/A
NCT01038102 Role of Dietary Fatty Acids in Fatty Liver and Insulin Resistance Status COMPLETED Phase NA
NCT00949403 Liver Positron Emission Tomography (PET) Study of Non Alcoholic Fatty Liver Disease Status COMPLETED Phase EARLY_PHASE1
NCT00885313 Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD) Status COMPLETED Phase PHASE1/PHASE2
NCT00862433 Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women Status COMPLETED Phase PHASE1